U.S. federal trademark · Serial No. 99500413
Downloadable and recorded software for providing direct interfaces between the brain and computer systems; downloadable and recorded software for directly controlling and communicating with computers and electronic devices via neural activity; downloadable and recorded software for controlling brain-computer interface (BCI) devices; downloadable and recorded software for interpreting and decoding neural activity; downloadable and recorded software for identifying biomarkers to train artificial intelligence (AI) and machine learning (ML) systems; Brain-computer interface (BCI) devices that allow users to interface with computer hardware via brain activity; interfaces for computers in the nature of implants for directly controlling and communicating with computers and electronic devices via neural activity
Providing online non-downloadable software featuring software that provides a direct interface between the brain and computer systems; software as a service (SAAS) services featuring software that allows users to directly control and communicate with computers using neural activity; providing online non-downloadable software for controlling brain-computer interface (BCI) devices; providing online non-downloadable software and recorded software for interpreting and decoding neural activity; providing online non-downloadable software for identifying biomarkers to train artificial intelligence (AI) and machine learning (ML) systems; research and development in the field of brain-computer interfaces (BCI), direct communication between brain activity and computers, neurostimulation, and therapeutics; providing information in the field of brain-computer interfaces (BCI); gene therapy research; research and development in the field of artificial intelligence (AI) and machine learning (ML) for use in brain-computer interface (BCI) devices, neurostimulation, and therapeutics
gene therapy products, namely, pharmaceutical preparations for enabling the use of brain computer interface (BCI) systems
Brain-computer interface (BCI) devices being ultrasound transceiver implants for medical use; implants for directly controlling and communicating with computers and electronic devices via neural activity for medical purposes; medical devices for opening the blood-brain barrier; electronic devices, namely, computer displays, monitors, and controllers therefor used for directly modulating brain states for the purpose of diagnosis of conditions and detecting brain activity in an individual; medical devices for detecting brain function
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.